Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS‐ACTS Substudy

BACKGROUND: The efficacy, safety, and ease of use of rivaroxaban may reduce anticoagulation‐treatment burden and improve nonvalvular atrial fibrillation (NVAF) patient satisfaction compared with vitamin K antagonists (VKAs). HYPOTHESIS: Transitioning from a VKA to rivaroxaban improves treatment sati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cardiol
Autors principals: Coleman, Craig I., Haas, Sylvia, Turpie, Alexander G.G., Kuhls, Silvia, Hess, Susanne, Evers, Thomas, Amarenco, Pierre, Kirchhof, Paulus, Camm, A. John
Format: Artigo
Idioma:Inglês
Publicat: Wiley Periodicals, Inc. 2016
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490868/
https://ncbi.nlm.nih.gov/pubmed/27362695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22565
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars